Cite
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections
MLA
Paola Brandi, et al. Trained Immunity Induction by the Inactivated Mucosal Vaccine MV130 Protects against Experimental Viral Respiratory Infections. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6655ea6db963d630136bc10e9a6c7b72&authtype=sso&custid=ns315887.
APA
Paola Brandi, Laura Conejero, Francisco J. Cueto, Sarai Martínez-Cano, Gillian Dunphy, Manuel J. Gómez, Carlos Relaño, Paula Saz-Leal, Michel Enamorado, Ana Quintas, Ana Dopazo, Joaquín Amores-Iniesta, Carlos del Fresno, Estanislao Nistal-Villán, Carlos Ardavín, Antonio Nieto, Miguel Casanovas, José Luis Subiza, & David Sancho. (2022). Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
Chicago
Paola Brandi, Laura Conejero, Francisco J. Cueto, Sarai Martínez-Cano, Gillian Dunphy, Manuel J. Gómez, Carlos Relaño, et al. 2022. “Trained Immunity Induction by the Inactivated Mucosal Vaccine MV130 Protects against Experimental Viral Respiratory Infections,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6655ea6db963d630136bc10e9a6c7b72&authtype=sso&custid=ns315887.